Search
Now showing items 1-10 of 424
EFICACIA E TOLERABILIDADE DA ASSOCIACAO CAPTOPRIL + HIDROCLOROTIAZIDA NO TRATAMENTO DA HIPERTENSAO ARTERIAL LEVE A MODERADA. ESTUDO MULTICENTRICO
(1995-08-09)
Purpose. To evaluate the antihypertensive efficacy and tolerability of captopril 50 mg + hydrochlorothiazide 25 mg daily in mild to moderate primary hypertension. Methods. Out-patients (n = 471) with mild to moderate ...
An update on the pharmacogenetics of treating hypertension
(Nature Publishing Group, 2015-05-01)
Hypertension is a leading cause of cardiovascular mortality, but only one third of patients achieve blood pressure goals despite antihypertensive therapy. Genetic polymorphisms may partially account for the interindividual ...
GABAergic Mechanisms Within The Nucleus of The Solitary Tract Contributes to The Anti-hypertensive Effetcs of Moxonidine
(Lippincott Williams & Wilkins, 2014)
GABAergic Mechanisms Within The Nucleus of The Solitary Tract Contributes to The Anti-hypertensive Effetcs of Moxonidine
(Lippincott Williams & Wilkins, 2011-11-01)
Antihypertensive therapy in pre-eclampsia: Effects of plasma from nonresponsive patients on endothelial gene expression
(2016-07-01)
Aim: Over 40% of patients with pre-eclampsia are nonresponsive to antihypertensive therapy, but the underlying mechanisms are unknown. We examined the effects of plasma from nonresponsive and responsive patients on endothelial ...
Pharmacogenomics of Hypertension and Preeclampsia: Focus on Gene-Gene Interactions
(Frontiers Media Sa, 2018-02-28)
Hypertension is a leading cause of cardiovascular mortality, but only about half of patients on antihypertensive therapy achieve blood pressure control. Preeclampsia is defined as pregnancy-induced hypertension and ...